PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.53 +0.02 (+4.08%)
As of: Aug 21, 2026 · 2:03 PM EDT

PharmaCyte Biotech (PMCB) FCF Margin (QoQ) (2010 - 2012)

PharmaCyte Biotech (PMCB) FCF Margin (QoQ) (2010 - 2012) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.93 Bn 131.08 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.11 Bn 78.11 Bn 3.93 Bn
3 Argenx Se 65.43 Bn 60.25 Bn 1.37 Bn
4 Moderna 56.09 Bn 50.96 Bn 52.00 Mn
5 BeOne Medicines 42.13 Bn 37.03 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.68 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.49 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 PharmaCyte Biotech 4.48 Mn 4.48 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2012 -5,524.00
Jul 31, 2012 -51,103.00
Apr 30, 2012 -59,937.00
Jan 31, 2012 8,159.00
Oct 31, 2011 34,547.00
Jul 31, 2011 -32,795.00
Apr 30, 2011 -6,217.00
Jan 31, 2011 -20,717.00
Oct 31, 2010 4,081.00